Korean stem cells regenerate coach Hiddink’s worn-out knee cartilage

MEDIPOST will set up a joint venture company in China

43% Increase in Dosage of CARTISTEM, for 4th Quarter of 2014 Year on Year

Nikkei Japan Reports the Status of MEDIPOST’s Stem Cell Research

Accumulated Dosage of CARTISTEM Exceeds 2,000 Cases

Administration of lung disease medicine ‘PNEUMOSTEM’ started in U.S. clinical trial

Administration of lung disease medicine ‘PNEUMOSTEM’ in clinical trial completed

The only Korean company invited to North American Rare Medicine conference

Participation in Biotec Japan and local publicity activities on CARTISTEM

U.S. ABC News gave intensified coverage on ‘CARTISTEM’

‘CARTISTEM’ injection to U.S. clinical trial subject completed

Lung disease medicine, ‘PNEUMOSTEM’ was designated as ‘Orphan Drug’ in Europe